The study presented here used global analyses to investigate differences and similarities between two types of CBF AML: the t(8;21) expressing RUNX1-ETO and the t(3;21) expressing RUNX1-EVI1, which both carry the same RUNX1 DNA-binding domain. The gene discussed is RUNX1; the disease is acute myeloid leukemia.